The Nephrotic Syndrome, Lipids, and Risk Factors for Cardiovascular Disease

Cameron, 1987, The nephrotic syndrome and its complications, Am J Kidney Dis, 10, 157, 10.1016/S0272-6386(87)80170-1 Appel, 1989, The hyperlipidemia of the nephrotic syndrome, Am J Med, 87, N45 Appel, 1985, The hyperlipidemia of the nephrotic syndrome, N Engl J Med, 312, 1544, 10.1056/NEJM198506133122404 Appel, 1991, Nephrology forum: Lipid abnormalities in renal disease, Kidney Int, 39, 169, 10.1038/ki.1991.22 Kaysen, 1991, Hyperlipidemia of the nephrotic syndrome, Kidney Int, 39, S41 Appel, 1991, Increase of plasma cholesteryl transfer ester protein concentration (CETP) in nephrotic syndrome, J Am Soc Nephrol, 2, 262 Keane, 1991, Hyperlipidemia and progressive renal disease, Kidney Int, 39, S41 Rabelink, 1990, Partial remission of the nephrotic syndrome in patients on long-term simvastatin, Lancet, 335, 1045, 10.1016/0140-6736(90)91118-T Maschio, 1989, Serum lipids in patients with chronic renal failure on long-term protein-restrictive diets, Am J Med, 87, N51 Kannel, 1990, CHD risk factors, A Framingham study update. Hosp Pract, 25, 119 Levy, 1987, Left ventricular mass predicts coronary disease events independent of standard risk factors, Circulation, 76, IV435 Aronow, 1988, Usefullness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherembolic brain infarction, Am J Cardiol, 61, 1130, 10.1016/0002-9149(88)90145-2 Ibels, 1977, Occlusive arterial disease in uremic and hemodialysis patients and renal transplant recipients, Q J Med, 44, 197 Rostand, 1979, Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis, Kidney Int, 16, 600, 10.1038/ki.1979.170 Hahn, 1983, Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemia, Atherosclerosis, 48, 279, 10.1016/0021-9150(83)90045-X Burke, 1978, Accelerated atherosclerosis in chronic dialysis patients-Another look, Nephron, 21, 181, 10.1159/000181391 Rostand, 1982, Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease, Kidney Int, 22, 304, 10.1038/ki.1982.170 Vincenti, 1980, The role of hypertension in hemodialysis-associated atherosclerosis, Am J Med, 68, 363, 10.1016/0002-9343(80)90104-7 Harnett, 1988, Left ventricular hypertrophy in end stage renal disease, Nephron, 48, 107, 10.1159/000184887 Ikran, 1983, Cardiovascular changes in chronic hemodialysis patients, Kidney Int, 24, 371, 10.1038/ki.1983.169 Haire, 1978, Smoking, hypertension and mortality in a maintenance dialysis population, Cardiovasc Med, 3, 1163 Vatsala, 1989, Lipid abnormalities in cyclosporine-prednisone treated renal transplant recipients, Transplantation, 48, 37, 10.1097/00007890-198907000-00009 Zilleruelo, 1984, Persistence of serum lipid abnormalities in children with idiopathic nephrotic syndrome, J Pediatr, 104, 61, 10.1016/S0022-3476(84)80590-9 Wass, 1979, Does the nephrotic syndrome increase the risk of cardiovascular disease?, Lancet, 2, 664, 10.1016/S0140-6736(79)92067-1 Gilboa, 1976, Incidence of coronary heart disease associated with nephrotic syndrome, Med J Aust, 1, 207, 10.5694/j.1326-5377.1976.tb140529.x Alexander, 1974, Increased incidence of coronary heart disease associated with combined elevations of serum triglycerides and cholesterol in the nephrotic syndrome in man, Med J Aust, 2, 119, 10.5694/j.1326-5377.1974.tb93641.x Hopper, 1970, Lipid nephrosis in 31 adult patients, Medicine, 49, 321, 10.1097/00005792-197007000-00004 Vosnides, 1974, Hyperlipidemia in renal disease, Med J Aust, 2, 855, 10.5694/j.1326-5377.1974.tb93714.x Berlyne, 1969, Ischemic heart disease as a complication of the nephrotic syndrome, Lancet, 2, 399, 10.1016/S0140-6736(69)90110-X Ordonez, 1990, The risk of coronary artery disease among patients with the nephrotic syndrome, Kidney Int, 37, 243 Curry, 1977, Status of the coronary arteries in the nephrotic syndrome, Am J Med, 63, 183, 10.1016/0002-9343(77)90231-5 Lindner, 1974, Accelerated atherosclerosis in prolonged maintenance hemodialysis, N Engl J Med, 290, 697, 10.1056/NEJM197403282901301 Attman, 1991, Lipid abnormalities in chronic renal insufficiency, Kidney Int, 38, S16 Avram, 1989, Cholesterol and lipid disturbances in renal disease: The natural history of uremic dyslipidemia and the impact of hemodialysis and CAPD, Am J Med, 85, N55N Silberberg, 1989, Impact of left ventricular hypertrophy on survival in end stage renal disease, Kidney Int, 36, 286, 10.1038/ki.1989.192 Parfrey, 1990, The clinical course of left ventricular hypertrophy in dialysis patients, Nephron, 55, 114, 10.1159/000185937 Rostand, 1984, Dialysis-associated ischemic heart disease: Insights from coronary angiography, Kidney Int, 25, 653, 10.1038/ki.1984.70 Ponticelli, 1992, Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy, N Engl J Med, 327, 599, 10.1056/NEJM199208273270904 Banfi, 1991, The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulonephritis with nephrotic syndrome in adults, Clin Nephrol, 36, 53 Jindal, 1992, Long-term benefits of therapy with cyclophosphomide and prednisone in patients with membranous glomerulonephritis and impaired renal function, Am J Kidney Dis, 19, 61, 10.1016/S0272-6386(12)70204-4 Bruns, 1991, Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone, Ann Intern Med, 114, 725, 10.7326/0003-4819-114-9-725 Mendoza, 1990, Treatment of steroid-resistant focal segmental glomerulonephritis with pulse methylprednisolone and alkylating agents, Pediatr Nephrol, 4, 303, 10.1007/BF00862503